These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 34306176)
1. miR-223-5p Suppresses OTX1 to Mediate Malignant Progression of Lung Squamous Cell Carcinoma Cells. Lu Y Comput Math Methods Med; 2021; 2021():6248793. PubMed ID: 34306176 [TBL] [Abstract][Full Text] [Related]
2. MiR-4652-5p Targets RND1 to Regulate Cell Adhesion and Promote Lung Squamous Cell Carcinoma Progression. Zhou Y; Yan J; Chen H; Zhou W; Xiao G; Zou H; Yang J Appl Biochem Biotechnol; 2022 Jul; 194(7):3031-3043. PubMed ID: 35334070 [TBL] [Abstract][Full Text] [Related]
3. MiR-195-5p suppresses gastric adenocarcinoma cell progression via targeting OTX1. Hu S; Zhou H; Zhao X; Qian F; Jin C Histol Histopathol; 2023 Jun; 38(6):659-668. PubMed ID: 36093844 [TBL] [Abstract][Full Text] [Related]
4. H3K27ac-activated LINC00519 promotes lung squamous cell carcinoma progression by targeting miR-450b-5p/miR-515-5p/YAP1 axis. Ye P; Lv X; Aizemaiti R; Cheng J; Xia P; Di M Cell Prolif; 2020 May; 53(5):e12797. PubMed ID: 32297697 [TBL] [Abstract][Full Text] [Related]
5. MiR-30a-5p hampers proliferation of lung squamous cell carcinoma through targeting FBXO45. Zeng F; You S; Dai X Histol Histopathol; 2022 May; 37(5):483-492. PubMed ID: 35098525 [TBL] [Abstract][Full Text] [Related]
6. MiR-497-5p down-regulates CDCA4 to restrains lung squamous cell carcinoma progression. Hu J; Xiang X; Guan W; Lou W; He J; Chen J; Fu Y; Lou G J Cardiothorac Surg; 2021 Nov; 16(1):330. PubMed ID: 34772428 [TBL] [Abstract][Full Text] [Related]
7. Knockdown of circMYOF inhibits cell growth, metastasis, and glycolysis through miR-145-5p/OTX1 regulatory axis in laryngeal squamous cell carcinoma. Li S; Zhang Y; He Z; Xu Q; Li C; Xu B Funct Integr Genomics; 2022 Aug; 22(4):1-13. PubMed ID: 35474406 [TBL] [Abstract][Full Text] [Related]
8. LncRNA RP11-116G8.5 promotes the progression of lung squamous cell carcinoma through sponging miR-3150b-3p/miR-6870-5p to upregulate PHF12/FOXP4. Li H; Zhao Q; Tang Z Pathol Res Pract; 2021 Oct; 226():153566. PubMed ID: 34500373 [TBL] [Abstract][Full Text] [Related]
9. miR-30a-5p Inhibits Proliferation and Migration of Lung Squamous Cell Carcinoma Cells by Targeting FOXD1. Chen C; Tang J; Xu S; Zhang W; Jiang H Biomed Res Int; 2020; 2020():2547902. PubMed ID: 32351986 [TBL] [Abstract][Full Text] [Related]
10. miR-30a-5p suppresses lung squamous cell carcinoma via ATG5 - mediated autophagy. Yang J; Rao S; Cao R; Xiao S; Cui X; Ye L Aging (Albany NY); 2021 Jul; 13(13):17462-17472. PubMed ID: 34253689 [TBL] [Abstract][Full Text] [Related]
11. miR-30a-5p Regulates Viability, Migration, and Invasion of Lung Adenocarcinoma Cells via Targeting ECT2. Chen S; Zhu X; Zheng J; Xu T; Xu Y; Chen F Comput Math Methods Med; 2021; 2021():6241469. PubMed ID: 34306175 [TBL] [Abstract][Full Text] [Related]
12. Expression of lncRNA LINC00943 in lung squamous cell carcinoma and its relationship with tumor progression. Zhao Z; Li H; Li J; Rong Y; Zhao L; Hao M; Tian F J Cardiothorac Surg; 2024 Apr; 19(1):222. PubMed ID: 38627774 [TBL] [Abstract][Full Text] [Related]
13. CircTIMELESS regulates the proliferation and invasion of lung squamous cell carcinoma cells via the miR-136-5p/ROCK1 axis. Zhang W; Shi J; Cheng C; Wang H J Cell Physiol; 2020 Sep; 235(9):5962-5971. PubMed ID: 31960961 [TBL] [Abstract][Full Text] [Related]
14. miR-139-5p Inhibits Lung Adenocarcinoma Cell Proliferation, Migration, and Invasion by Targeting MAD2L1. Li J; He X; Wu X; Liu X; Huang Y; Gong Y Comput Math Methods Med; 2020; 2020():2953598. PubMed ID: 33204298 [TBL] [Abstract][Full Text] [Related]
15. [Mechanism Research of lncRNA miR143HG on Regulating the Biological Behavior of Lung Squamous Cell Carcinoma H520 Cells]. Gou L; He Y; Qiu P; Huang B Zhongguo Fei Ai Za Zhi; 2023 Oct; 26(10):741-752. PubMed ID: 37989337 [TBL] [Abstract][Full Text] [Related]
16. MiR-139-3p Targets CHEK1 Modulating DNA Repair and Cell Viability in Lung Squamous Carcinoma Cells. Zheng X; Zhang Y; Wu S; Jiang B; Liu Y Mol Biotechnol; 2022 Jul; 64(7):832-840. PubMed ID: 35150405 [TBL] [Abstract][Full Text] [Related]
17. Investigation of miR-136-5p key target genes and pathways in lung squamous cell cancer based on TCGA database and bioinformatics analysis. Xie ZC; Li TT; Gan BL; Gao X; Gao L; Chen G; Hu XH Pathol Res Pract; 2018 May; 214(5):644-654. PubMed ID: 29650443 [TBL] [Abstract][Full Text] [Related]
18. LINC01232 promotes lung squamous cell carcinoma progression through modulating miR-181a-5p/SMAD2 axis. Zhang D; Hua M; Zhang N Am J Med Sci; 2023 Apr; 365(4):386-395. PubMed ID: 36543302 [TBL] [Abstract][Full Text] [Related]
19. Clinical value of miR-182-5p in lung squamous cell carcinoma: a study combining data from TCGA, GEO, and RT-qPCR validation. Luo J; Shi K; Yin SY; Tang RX; Chen WJ; Huang LZ; Gan TQ; Cai ZW; Chen G World J Surg Oncol; 2018 Apr; 16(1):76. PubMed ID: 29636077 [TBL] [Abstract][Full Text] [Related]
20. DLX6-AS1 activated by H3K4me1 enhanced secondary cisplatin resistance of lung squamous cell carcinoma through modulating miR-181a-5p/miR-382-5p/CELF1 axis. Zhao X; Wang J; Zhu R; Zhang J; Zhang Y Sci Rep; 2021 Oct; 11(1):21014. PubMed ID: 34697393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]